Evidence map›Paper›PMID 35357044›Full record

ArticleXenotransplantation2022

Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months.

Muhammad M Mohiuddin, Corbin E Goerlich, Avneesh K Singh, Tianshu Zhang, Ivan Tatarov, Billeta Lewis, Faith Sentz, Alena Hershfeld, Gheorghe Braileanu, Patrick Odonkor and 15 more

Open access · greenAbstract read
In one paragraph

Article in Xenotransplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
26.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Gene-edited pig cardiac xenotransplantation as a bridge to allotransplantation in infants: Progress in a pig-to-baboon model.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Early Results of an Infant Model of Orthotopic Cardiac Xenotransplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Allogeneic, Xenogeneic, and Exogenic Hearts for Transplantation.Methodist DeBakey cardiovascular journal · 2025
    Review
  17. Review
  18. Cytotoxic Responses Mediated by NK Cells and Cytotoxic T Lymphocytes in Xenotransplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  19. Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2024
    Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 2 institutions in 1 country.

Muhammad M MohiuddinDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Corbin E GoerlichDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Avneesh K SinghDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Tianshu ZhangDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ivan TatarovDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Billeta LewisDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Faith SentzDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Alena HershfeldDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Gheorghe BraileanuDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Patrick OdonkorDepartment of Anesthesiology, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Erik StraussDepartment of Anesthesiology, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Brittney WilliamsDepartment of Anesthesiology, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Allen BurkeDepartment of Pathology, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jamie HittmanDepartment of Pathology, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Adnan BhuttaDepartment of Pediatrics, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ali TabatabaiDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Anuj GuptaDepartment of Medicine, Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Todd VaughtRevivicor, Inc., Blacksburg, Virginia, USA.
Lori SorrellsRevivicor, Inc., Blacksburg, Virginia, USA.
Kasinath KuraviRevivicor, Inc., Blacksburg, Virginia, USA.
Amy DandroRevivicor, Inc., Blacksburg, Virginia, USA.
Will EyestoneRevivicor, Inc., Blacksburg, Virginia, USA.
David J KaczorowskiDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
David AyaresRevivicor, Inc., Blacksburg, Virginia, USA.
Bartley P GriffithDepartment of Surgery, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USVirginia Tech · US

Funding

Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammationU19AI090959 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COOPER, DAVID KC · 2010 to 2024
$26.3M
NIAID NIH HHS U19 AI090959
6 · The paper itself

Abstract

We report orthotopic (life-supporting) survival of genetically engineered porcine cardiac xenografts (with six gene modifications) for almost 9 months in baboon recipients. This work builds on our previously reported heterotopic cardiac xenograft (three gene modifications) survival up to 945 days with an anti-CD40 monoclonal antibody-based immunosuppression. In this current study, life-supporting xenografts containing multiple human complement regulatory, thromboregulatory, and anti-inflammatory proteins, in addition to growth hormone receptor knockout (KO) and carbohydrate antigen KOs, were transplanted in the baboons. Selective "multi-gene" xenografts demonstrate survival greater than 8 months without the requirement of adjunctive medications and without evidence of abnormal xenograft thickness or rejection. These data demonstrate that selective "multi-gene" modifications improve cardiac xenograft survival significantly and may be foundational for paving the way to bridge transplantation in humans.

Indexed as

Graft RejectionHeart TransplantationAnimalsAnimals, Genetically ModifiedGraft SurvivalHeterograftsHumansImmunosuppressive AgentsPapioSwineTransplantation, HeterologousImmunosuppressive Agentscardiac xenotransplantationCRISPRheart failurepig heartxenotransplantation

Identifiers

PMID35357044
PMCPMC10325874
OpenAlexW4220666278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.